SCHEMBL6558652

SCHEMBL6558652

CCS(=O)(=O)N(Cc1ccccc1)C1CC(C)(C)Oc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNE1 P15382 4/20 0.44
KCNQ1 P51787 4/20 0.44
LMNA P02545 3/20 0.38
NPSR1 Q6W5P4 2/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TRPV1 Q8NER1 2/20 0.37
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
CA2 P00918 1/20 0.33
CTSD P07339 1/20 0.33
BACE1 P56817 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559337 0.88 KCNE1 (0.47) KCNE1KCNQ1LMNATRPV1ALDH1A1
SCHEMBL6559313 0.83 KCNE1 (0.46) KCNE1KCNQ1LMNANPSR1TSHR
SCHEMBL6559524 0.81 KCNE1 (0.57) KCNE1KCNQ1LMNATRPV1ALDH1A1
SCHEMBL6559544 0.76 KCNA5 (0.36) KCNE1KCNQ1NPSR1SMN1; SMN2ALDH1A1
SCHEMBL6601915 0.75 KCNE1 (0.57) KCNE1KCNQ1NPSR1SMN1; SMN2ALDH1A1
SCHEMBL6560836 0.73 KCNA5 (0.34) KCNE1KCNQ1NPSR1SMN1; SMN2ALDH1A1
SCHEMBL6559417 0.72 KCNE1 (0.37) KCNE1KCNQ1TRPV1KMT2A
SCHEMBL6559266 0.72 KCNE1 (0.52) KCNE1KCNQ1TRPV1
SCHEMBL6559403 0.72 KCNA5 (0.37) LMNANPSR1TSHRSMN1; SMN2ALDH1A1
SCHEMBL6559500 0.72 NPSR1 (0.38) KCNE1KCNQ1NPSR1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed